Invention Application
- Patent Title: GOLD-COATED STENT COATED/PLATED THE CHEMICALS AND OLIGONUCLEOTIDE BINDING GOLD-COATED STENT AND PROCESS FOR PRODUCING THE SAME
-
Application No.: PCT/KR2008/003385Application Date: 2008-06-16
-
Publication No.: WO2008156270A3Publication Date: 2008-12-24
- Inventor: PARK, Han-Oh , LEE, Jae-Don , LEE, Sam-Yong , JUNG, Eun-Jung
- Applicant: BIONEER CORPORATION , PARK, Han-Oh , LEE, Jae-Don , LEE, Sam-Yong , JUNG, Eun-Jung
- Applicant Address: 49-3, Munpyeong-dong Daedeok-gu Daejeon, 306-220 KR
- Assignee: BIONEER CORPORATION,PARK, Han-Oh,LEE, Jae-Don,LEE, Sam-Yong,JUNG, Eun-Jung
- Current Assignee: BIONEER CORPORATION,PARK, Han-Oh,LEE, Jae-Don,LEE, Sam-Yong,JUNG, Eun-Jung
- Current Assignee Address: 49-3, Munpyeong-dong Daedeok-gu Daejeon, 306-220 KR
- Agency: KWON, Oh-Sig et al.
- Priority: KR10-2007-0059828 20070619
- Main IPC: A61L27/28
- IPC: A61L27/28
Abstract:
The present invention relates to a gold-plated stent and its preparation method. More specifically, it relates to a gold- plated stent that is coated with various chemical materials such as 2-aminoalkanethiol, epihalogenhydrin, and diamine compounds in a sequence and also oligonucleotide gold-plated stent, which is prepared by binding oligonucleotide, a biomaterial, to the gold- plated stent coated with said chemicals. The oligonucleotide gold-plated stent of the present invention has an advantages of raising the local concentration in injured parts and minimizing the toxicity overall the body, so it can be used for prevention of restenosis after angioplasty.
Information query
